SJN
Sung Ji Nam Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
34%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.2%
Neutral
23.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $60 |
46%
downside
| 3 | +50% |
0
%
| 31 Jul ‘25 5 months ago |
|
|
|
Sector Outperform
Maintained
| $75 |
14%
upside
| 2 | -3.5% |
0
%
| 11 Jul ‘25 6 months ago |
|
|
|
Sector Outperform
Upgraded
| $275 |
15%
upside
| 1 | +16% |
0
%
| 11 Jul ‘25 6 months ago |
|
|
|
Sector Outperform
Upgraded
| $590 |
5%
downside
| 3 | +44% |
0
%
| 11 Jul ‘25 6 months ago |
|
|
|
Sector Perform
Downgraded
| $125 |
11%
downside
| 1 | – |
–
| 11 Jul ‘25 6 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
2%
upside
| 1 | +138% |
0
%
| 21 May ‘25 7 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
633%
upside
| 1 | +0.74% |
0
%
| 21 May ‘25 7 months ago |
|
|
|
Sector Perform
Downgraded
| $6 |
9%
downside
| 2 | -50% |
0
%
| 21 May ‘25 7 months ago |
|
|
|
Sector Perform
Maintained
| $4 |
153%
upside
| 1 | – |
–
| 2 Apr ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $18 |
123%
upside
| 1 | +12% |
0
%
| 25 Mar ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $2 |
3%
upside
| 1 | +46% |
0
%
| 25 Mar ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $73 |
29%
downside
| 1 | +107% |
0
%
| 24 Feb ‘25 10 months ago |
|
|
|
Sector Outperform
Maintained
| $12 |
24%
downside
| 1 | +109% |
0
%
| 13 Feb ‘25 11 months ago |
|
|
|
Sector Outperform
Upgraded
| $450 |
13%
upside
| 1 | +3.9% |
0
%
| 13 Feb ‘25 11 months ago |
|
|
|
Sector Outperform
Maintained
| $62 |
76%
upside
| 1 | -33% |
0
%
| 4 Feb ‘25 11 months ago |
|